肺癌鉴别诊断、转化及治疗标志物和耐药机制研究

Differential diagnosis, histologic transformation, biomarkers and drug resistance mechanism of lung cancer

上海市肺科医院病理科副主任

Deputy director of pathology department, shanghai pulmonary hospital

上海市医学会病理专科分会 青年委员

Pathological Committee of Shanghai Medical Association

中华医学会病理学分会病理大数据委员会 委员

Pathological Big Data Committee of Chinese Pathological Society

中华医学会结核病学分会病理专业委员会 委员

Pathological Committee of the Society of Tuberculosis, Chinese Medical Association

上海市医学会分子诊断委员会 委员

Molecular Diagnosis Committee of Shanghai Medical Association

从事胸部专科临床病理工作10余年，主要研究肺癌和胸腺瘤鉴别诊断、肺癌分子病理和耐药机制。主持国家自然科学基金、上海市卫生健康委课题（面上项目）和新疆自然科学基金各一项。发表SCI专业学术论文40余篇，其中第一作者或并列作者近20篇。获得2022年上海市卫生健康委员会“医苑新星”杰出青年医学人才、上海市肺科医院青年人才计划。获得2020年国家留学基金委访问学者资助。

I have worked on clinical thoracic pathology over 10 years，focusing on differential diagnosis of lung cancer and mediastinal thymic tumors. My interest in molecular pathology and drug resistance of lung cancer resulted in leading of National Natural Science Foundation of China, Shanghai Municipal Health Commission (General program) and XinJiang Natural Science Foundation. I have published more than 40 SCI articles about lung cancer, including nearly 20 articles as the first author or co-author, and been supported by Youth talents programs of Shanghai municipal health commission and Shanghai pulmonary hospital, and been awarded the Chinese Government Scholarship to sponsor study abroad in 2020.